UPDATE: Barclays Starts Bicycle Therapeutics (BCYC) at Overweight

July 28, 2022 3:24 AM EDT Send to a Friend
(Updated - July 28, 2022 5:48 AM EDT)

Barclays analyst Peter Lawson initiates coverage on Bicycle Therapeutics (NASDAQ: BCYC) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login